Log In
Print
BCIQ
Print
Print this Print this
 

BT2111

  Manage Alerts
Collapse Summary General Information
Company biOasis Technologies Inc.
DescriptionTrastuzumab conjugated to the Transcend p97 carrier protein
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentPreclinical
IndicationBrain cancer
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today